A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: the pitfalls of ciprofloxacin

被引:21
|
作者
Wazait, HD
Patel, HR
van der Meulen, JHP
Ghei, M
Al-Buheissi, S
Kelsey, M
Miller, RA
Emberton, M
机构
[1] Royal Coll Surgeons England, Clin Effectiveness Unit, London WC2A 3PN, England
[2] Whittington Hosp NHS Trust, Dept Urol, London, England
[3] Whittington Hosp NHS Trust, Dept Microbiol, London, England
[4] London Sch Hyg & Trop Med, London WC1, England
关键词
catheter; urinary tract infections; nosocomial infection;
D O I
10.1111/j.1464-410X.2004.05102.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To assess if a short course of antibiotics starting at the time of the removing a short-term urethral catheter decreases the incidence of subsequent urinary tract infection (UTI). PATIENTS AND METHODS Patients across specialities with a urethral catheter in situ for greater than or equal to 48 h and less than or equal to 7 days were recruited at the time of catheter removal. Patients were excluded if they had had recent genitourinary surgery or were on antibiotics. Eligible patients were randomly assigned to a 48-h course of either ciprofloxacin or placebo tablets starting 2 h before catheter removal. A catheter specimen of urine was obtained before the start of the trial medication. The follow-up was at 7 and 14 days after catheter removal, with a questionnaire for UTI symptoms, and a mid-stream urine sample was taken. RESULTS Forty-eight patients were recruited and had a complete follow-up (25 received ciprofloxacin and 23 placebo). Of the ciprofloxacin group, four patients (16%) had a UTI at the follow-up after catheter removal, and two were symptomatic. The UTI in two patients (including one of those symptomatic) was newly developed after catheter removal; the other two UTIs were a result of failure to resolve a catheter-associated UTI. All these UTIs in the ciprofloxacin group were resistant to ciprofloxacin. Of the placebo group, three patients (13%) had a UTI at the follow-up after removal, and one patient was symptomatic. The UTI, newly developed after catheter removal, was resistant to ciprofloxacin. The other two patients were asymptomatic; their UTIs were a result of failure to resolve a catheter-associated UTI, and one was resistant to ciprofloxacin. CONCLUSIONS The risk of UTI (both symptomatic and asymptomatic) after removing a urethral catheter is real, even in absence of catheter-associated UTI before removal. UTIs occurring after removing a short-term urinary catheter had a high rate of resistance to ciprofloxacin. There was no detectable significant benefit in using prophylactic ciprofloxacin to reduce the UTI rate after catheter removal.
引用
收藏
页码:1048 / 1050
页数:3
相关论文
共 50 条
  • [1] A pilot randomized double-blind placebo-controlled trial on the use of antibiotics on urinary catheter removal to reduce the rate of urinary tract infection: The pitfalls of ciprofloxacin
    Qazi, HAZ
    Philip, J
    Manikandan, R
    Cornford, PA
    BJU INTERNATIONAL, 2005, 95 (04) : 681 - 682
  • [2] Do antibiotics on urinary catheter withdrawal prevent the incidence of urinary tract infection? A pilot randomised double-blind placebo-controlled study
    Wazait, HD
    Patel, HR
    Van der Meulen, JHP
    Miller, RA
    Emberton, M
    JOURNAL OF UROLOGY, 2003, 169 (04): : 9 - 9
  • [3] Single-dose antibiotic prophylaxis for urinary catheter removal does not reduce the risk of urinary tract infection in surgical patients: a randomized double-blind placebo-controlled trial
    van Hees, B. C.
    Vijverberg, P. L. M.
    Hoorntje, L. E.
    Wiltink, E. H. H.
    Go, P. M. N. Y. H.
    Tersmette, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (07) : 1091 - 1094
  • [4] Bacterial interference for prevention of urinary tract infection: A prospective, randomized, placebo-controlled, double-blind pilot trial
    Darouiche, RO
    Thornby, JI
    Cerra-Stewart, C
    Donovan, WH
    Hull, RA
    CLINICAL INFECTIOUS DISEASES, 2005, 41 (10) : 1531 - 1534
  • [5] Should prophylactic antibiotics be given on urinary catheter withdrawal? A randomized double-blind placebo-controlled trial
    Wazait, HD
    Patel, HRH
    Kumar, V
    Kelsey, M
    Van der Meulen, JHP
    Miller, RA
    Emberton, M
    BJU INTERNATIONAL, 2003, 92 (07) : 829 - 829
  • [7] POSTCOITAL ANTIMICROBIAL PROPHYLAXIS FOR RECURRENT URINARY-TRACT INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    STAPLETON, A
    LATHAM, RH
    JOHNSON, C
    STAMM, WE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (06): : 703 - 706
  • [8] A PLACEBO-CONTROLLED RANDOMIZED TRIAL OF ANTIBIOTICS FOR THE PREVENTION OF URINARY TRACT INFECTION IN CHILDREN
    Craig, J.
    Simpson, J.
    Lowe, A.
    Reynolds, G.
    Mctaggart, S.
    Hodson, E.
    Carapetis, J.
    Irwig, L.
    Roy, P.
    NEPHROLOGY, 2008, 13 : A122 - A122
  • [9] A randomised double-blind placebo-controlled trial of prophylactic antibiotics in preventing female urinary tract infection after urodynamic study
    Yip, S.
    Cheon, C.
    Wong, T.
    Pang, M.
    Lee, L.
    Yuen, C.
    Choy, K.
    NEUROUROLOGY AND URODYNAMICS, 2006, 25 (06) : 627 - 628
  • [10] Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms
    Gerber, GS
    Kuznetsov, D
    Johnson, BC
    Burstein, JD
    UROLOGY, 2001, 58 (06) : 960 - 963